MoneyWorks4Me

Biocon’s Q3 consolidated net declines 16%

25 Jan 2012 Evaluate

Biocon has reported results for its third quarter ended December 31, 2011.

The company has posted a 69.41% fall in net profit of Rs 64.73 crore for the quarter ended December 31, 2011 as compared to Rs 211.59 crore for the same quarter in the previous year. Total income has decreased by 23.19% from Rs 515.94 crore for Q3FY11 to Rs 396.30 crore in the quarter under review.

On the consolidated basis the group has posted a net profit fall of 15.79% to Rs 84.85 crore for the quarter ended December 31, 2011 as compared to Rs 100.76 crore in the same quarter last year. Total Income of the company improved marginally by 2.65% to Rs 532.18 crore for the quarter compared to Rs 518.44 crore in the quarter, year ago.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..